Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P61006
UPID:
RAB8A_HUMAN
Alternative names:
Oncogene c-mel
Alternative UPACC:
P61006; B4DEK7; P24407; Q6FHV5
Background:
Ras-related protein Rab-8A, also known as Oncogene c-mel, plays a pivotal role in intracellular membrane trafficking. It regulates the transition between inactive GDP-bound and active GTP-bound forms, facilitating vesicle formation, movement, and fusion. Rab-8A is crucial for polarized vesicular trafficking, neurotransmitter release, and processes such as lumenogenesis, Golgi morphology, epithelial cell polarization, ciliogenesis, and possibly glucose homeostasis.
Therapeutic significance:
Understanding the role of Ras-related protein Rab-8A could open doors to potential therapeutic strategies.